North Fourth Asset Management’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-10,441
Closed -$2.61M 71
2018
Q3
$2.61M Buy
+10,441
New +$2.25M 0.91% 35

Other funds holding CDLX

North Fourth Asset Management's CDLX Position: Q4 2018 in Review

North Fourth Asset Management sold out of Cardlytics (CDLX) in Q4 2018, closing a stake of 10,441 shares — an estimated $2.61M sold.

North Fourth Asset Management first reported a position in CDLX in Q3 2018 and held it in 1 quarter. The position peaked at $2.61M in Q3 2018. 61 funds tracked by Wall St. Rank hold CDLX as of Q4 2018.

  • North Fourth Asset Management reported no remaining Cardlytics position as of Q4 2018 after selling out during the quarter.
  • North Fourth Asset Management sold 10,441 Cardlytics shares in Q4 2018, an estimated $2.61M.
  • North Fourth Asset Management first reported a position in Cardlytics in Q3 2018 and held it in 1 quarter.
  • North Fourth Asset Management's Cardlytics position peaked at $2.61M in Q3 2018.
  • 61 funds tracked by Wall St. Rank held Cardlytics as of Q4 2018.

Based on North Fourth Asset Management's 13F filing for Q4 2018, filed 13 Feb 2019.